Avidity Biosciences Inc (RNA) USD0.0001

Sell:$27.50Buy:$33.04$1.02 (3.17%)

Prices delayed by at least 15 minutes
Sell:$27.50
Buy:$33.04
Change:$1.02 (3.17%)
Prices delayed by at least 15 minutes
Sell:$27.50
Buy:$33.04
Change:$1.02 (3.17%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
11 March 2025
W Michael FlanaganChief Level Officer
Sell
Option/Award related
20,000$30.13$602,614.0091,975
3 March 2025
Kathleen P GallagherChief Level Officer
Sell
Option/Award related
5,875$29.41$172,807.2550,554
3 February 2025
Kathleen P GallagherChief Level Officer
Sell
Option/Award related
5,875$32.16$188,918.2650,554
22 January 2025
Kathleen P GallagherChief Level Officer
Sell
Regular sell transaction (market)
5,629$30.16$169,775.7150,554
21 January 2025
Sarah BoycePresident/CEO
Sell
Tax related
4,738$28.59$135,474.58343,070
21 January 2025
Sarah BoycePresident/CEO
Sell
Tax related
5,659$28.59$161,816.84337,411
21 January 2025
Michael F. MacLeanCFO
Sell
Tax related
1,622$28.59$46,377.68106,320
21 January 2025
Teresa McCarthyGroup Director
Sell
Tax related
1,738$28.59$49,694.81106,129
21 January 2025
Teresa McCarthyGroup Director
Sell
Tax related
1,221$28.60$34,916.69104,908
21 January 2025
Michael F. MacLeanCFO
Sell
Tax related
1,665$28.59$47,607.68104,655

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
13 June 2024
Sarah BoycePresident/CEO
Sell
Option/Award related
164,233$40.08$6,581,801.71112,117
12 June 2024
Michael F. MacLeanCFO
Sell
Option/Award related
104,245$35.72$3,723,141.4544,093
12 June 2024
Sarah BoycePresident/CEO
Sell
Option/Award related
100,000$35.73$3,573,020.00112,117
1 October 2024
W Michael FlanaganChief Level Officer
Sell
Option/Award related
62,500$47.62$2,976,112.5085,389
6 November 2024
Michael F. MacLeanCFO
Sell
Option/Award related
65,182$45.33$2,954,954.2794,093

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.